BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25622735)

  • 1. [Evaluations and analyses of quality of life in 90 patients with systemic sclerosis by health assessment questionnaire-disability index].
    Mao X; Sun Q
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(44):3471-4. PubMed ID: 25622735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time.
    Steen VD; Medsger TA
    Arthritis Rheum; 1997 Nov; 40(11):1984-91. PubMed ID: 9365087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis.
    Hesselstrand R; Nilsson JÅ; Sandqvist G
    Scand J Rheumatol; 2013; 42(4):317-24. PubMed ID: 23442162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
    Johnson SR; Glaman DD; Schentag CT; Lee P
    J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).
    Georges C; Chassany O; Mouthon L; Tiev K; Toledano C; Meyer O; Marjanovic Z; Heneggar C; Papo T; Crickx B; Sereni D; Cabane J; Farge D
    Clin Rheumatol; 2005 Feb; 24(1):3-10. PubMed ID: 15674652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Turkish version of the Scleroderma Health Assessment Questionnaire.
    Temiz Karadag D; Karakas F; Tekeoglu S; Yazici A; Isik OO; Cefle A
    Clin Rheumatol; 2019 Jul; 38(7):1917-1923. PubMed ID: 30840212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin R; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold J
    Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case-control study.
    Chan PT; Mok CC; Chan KL; Ho LY
    Clin Rheumatol; 2014 May; 33(5):659-66. PubMed ID: 24531870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools.
    Strickland G; Pauling J; Cavill C; McHugh N
    Clin Rheumatol; 2012 Aug; 31(8):1215-22. PubMed ID: 22588647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis.
    Nagy G; Dobrota R; Becker MO; Minier T; Varjú C; Kumánovics G; Distler O; Czirják L
    Arthritis Res Ther; 2023 May; 25(1):84. PubMed ID: 37210571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual function in Italian women with systemic sclerosis is affected by disease-related and psychological concerns.
    Maddali Bongi S; Del Rosso A; Mikhaylova S; Baccini M; Matucci Cerinic M
    J Rheumatol; 2013 Oct; 40(10):1697-705. PubMed ID: 23996290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
    Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
    J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.
    Sekhon S; Pope J; ; Baron M
    J Rheumatol; 2010 Mar; 37(3):591-8. PubMed ID: 20080913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
    Kowal-Bielecka O; Avouac J; Pittrow D; Huscher D; Behrens F; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE; Distler O;
    J Rheumatol; 2011 Nov; 38(11):2419-27. PubMed ID: 21965635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis.
    Ng X; Thumboo J; Low AH
    Int J Rheum Dis; 2012 Jun; 15(3):268-76. PubMed ID: 22709488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cortisol levels and pain threshold in systemic sclerosis and major depression.
    Bagnato G; Cordova F; Sciortino D; Miceli G; Bruno A; Ferrera A; Sangari D; Coppolino G; Muscatello MRA; Pandolfo G; Zoccali RA; Roberts WN
    Rheumatol Int; 2018 Mar; 38(3):433-441. PubMed ID: 29086069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
    Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
    Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.